• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Director Paglia John Kenneth was granted 787 shares, increasing direct ownership by 15% to 6,065 units (SEC Form 4)

    2/4/25 5:41:42 PM ET
    $SLP
    EDP Services
    Technology
    Get the next $SLP alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Paglia John Kenneth

    (Last) (First) (Middle)
    800 PARK OFFICES DRIVE
    SUITE 401

    (Street)
    RESEARCH TRIANGLE PARK NC 27709

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Simulations Plus, Inc. [ SLP ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    02/03/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 02/03/2025 A 787 A $0(1) 6,065 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Stock granted as independent director compensation, issued under the issuer's 2021 Equity Incentive Plan.
    Remarks:
    /s/ Daniel Hoeft, attorney-in-fact for John Kenneth Paglia 02/04/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $SLP alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $SLP

    DatePrice TargetRatingAnalyst
    7/15/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    11/15/2024$39.00Overweight
    Stephens
    7/29/2024$47.00Overweight
    KeyBanc Capital Markets
    7/16/2024Mkt Perform
    JMP Securities
    6/28/2024Outperform
    William Blair
    5/9/2023$55.00Buy
    BTIG Research
    10/26/2021$65.00 → $53.00Hold → Buy
    Craig Hallum
    7/13/2021$95.00 → $54.00Outperform
    Raymond James
    More analyst ratings

    $SLP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Simulations Plus Invests in Clinical Development Technology Company Nurocor

      Investment to accelerate innovations in biopharma development through Corporate Development Initiative Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced an investment of $1 million in technology company Nurocor. Founded in 2017, Nurocor offers a cloud-based software platform designed to improve efficiency, reusability, governance, and automation for pharmaceutical companies through digitalization in the clinical development phase. Its solution significantly accelerates the typical clinical trial lif

      7/14/25 4:15:00 PM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results

      Updated full-year revenue guidance of between $76 to $80 million and adjusted diluted EPS of $0.93 to $1.06 Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its third quarter fiscal 2025, ended May 31, 2025. Third Quarter 2025 Financial Highlights (as compared to third quarter 2024) Total revenue increased 10% to $20.4 million Software revenue increased 6% to $12.6 million, representing 62% of total revenue Services revenue increased 17% to $7.7 millio

      7/14/25 4:05:00 PM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum

      Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus", "SLP"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn O'Connor, Chief Executive Officer, will be participating in the Citizens Medical Devices and Healthcare Services Forum taking place in Boston, Massachusetts. Mr. O'Connor will host one-on-one meetings with institutional investors on Tuesday, June 17, 2025. For more information about the events or questions about registration, interested parties should reach out to their contacts at Citizens. About Simulations Plus, Inc. With more

      6/12/25 7:50:00 AM ET
      $SLP
      EDP Services
      Technology

    $SLP
    SEC Filings

    See more
    • SEC Form 10-Q filed by Simulations Plus Inc.

      10-Q - Simulations Plus, Inc. (0001023459) (Filer)

      7/15/25 8:02:18 AM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

      8-K - Simulations Plus, Inc. (0001023459) (Filer)

      7/15/25 7:56:13 AM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Simulations Plus, Inc. (0001023459) (Filer)

      7/14/25 4:49:27 PM ET
      $SLP
      EDP Services
      Technology

    $SLP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Woltosz Walter S sold $366,623 worth of shares (20,000 units at $18.33), decreasing direct ownership by 0.60% to 3,304,157 units (SEC Form 4)

      4 - Simulations Plus, Inc. (0001023459) (Issuer)

      7/2/25 4:24:37 PM ET
      $SLP
      EDP Services
      Technology
    • Director Woltosz Walter S sold $543,074 worth of shares (20,000 units at $27.15), decreasing direct ownership by 0.60% to 3,324,157 units (SEC Form 4)

      4 - Simulations Plus, Inc. (0001023459) (Issuer)

      6/3/25 4:57:16 PM ET
      $SLP
      EDP Services
      Technology
    • Director Woltosz Walter S was granted 786 shares and sold $670,150 worth of shares (20,000 units at $33.51), decreasing direct ownership by 0.57% to 3,344,157 units (SEC Form 4)

      4 - Simulations Plus, Inc. (0001023459) (Issuer)

      5/1/25 5:53:05 PM ET
      $SLP
      EDP Services
      Technology

    $SLP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Simulations Plus downgraded by KeyBanc Capital Markets

      KeyBanc Capital Markets downgraded Simulations Plus from Overweight to Sector Weight

      7/15/25 8:39:07 AM ET
      $SLP
      EDP Services
      Technology
    • Stephens initiated coverage on Simulations Plus with a new price target

      Stephens initiated coverage of Simulations Plus with a rating of Overweight and set a new price target of $39.00

      11/15/24 8:20:56 AM ET
      $SLP
      EDP Services
      Technology
    • KeyBanc Capital Markets initiated coverage on Simulations Plus with a new price target

      KeyBanc Capital Markets initiated coverage of Simulations Plus with a rating of Overweight and set a new price target of $47.00

      7/29/24 7:43:47 AM ET
      $SLP
      EDP Services
      Technology

    $SLP
    Financials

    Live finance-specific insights

    See more
    • Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results

      Updated full-year revenue guidance of between $76 to $80 million and adjusted diluted EPS of $0.93 to $1.06 Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its third quarter fiscal 2025, ended May 31, 2025. Third Quarter 2025 Financial Highlights (as compared to third quarter 2024) Total revenue increased 10% to $20.4 million Software revenue increased 6% to $12.6 million, representing 62% of total revenue Services revenue increased 17% to $7.7 millio

      7/14/25 4:05:00 PM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue

      Updates fiscal 2025 revenue guidance range Third quarter fiscal 2025 full results to be released on July 2, 2025, with conference call at 5 p.m. ET Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary revenue for its third fiscal quarter and updated its full year 2025 revenue guidance. The Company expects to report third quarter fiscal 2025 revenue in the range of between $19 million and $20 million Full year fiscal 2025 revenue is expected to range between $76 millio

      6/11/25 4:30:00 PM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results

      Total revenue grew 23% year-over-year driven by strong growth in both software and services Maintains full-year revenue guidance of $90 to $93 million and adjusted diluted EPS of $1.07 to $1.20 Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its second quarter fiscal 2025, ended February 28, 2025. Second Quarter 2025 Financial Highlights (as compared to second quarter 2024) Total revenue increased 23% to $22.4 million Software revenue increased 16% to $13.5 million, repres

      4/3/25 4:05:00 PM ET
      $SLP
      EDP Services
      Technology

    $SLP
    Leadership Updates

    Live Leadership Updates

    See more
    • QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus

      QHP Capital, L.P. ("QHP"), an investor in technology and services companies in the life sciences and healthcare sectors, today announced its sale of Pro-ficiency, LLC ("Pro-ficiency" or the "Company"), a leader in providing tech-enabled training and compliance solutions for clinical trial investigators and site staff, to Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy. Michael Raymer, Chief Executive Officer of Pro-ficiency, said, "We are excited to join the Simulations Plus team, which has a well-established and recognized leadership position in modeling and simulations wi

      6/12/24 8:58:00 AM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer

      LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), announced today the appointment of Will Frederick as chief financial officer (CFO), succeeding John Kneisel, who retires after seven years with the company. Will Frederick brings more than 25 years of financial leadership experience to the company. He has a proven track record of developing and implementing strategies to drive revenue growth, increase profitability, managing merger & acquisition activities and achieving corporate objectives. He has global experience with both publicly traded and privately held companies including Pharsight, Entelos, Avaya, The Walt Disney Company and Ford Motor Company, among

      12/1/20 4:05:00 PM ET
      $DIS
      $SLP
      $F
      Services-Misc. Amusement & Recreation
      Consumer Discretionary
      EDP Services
      Technology

    $SLP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Simulations Plus Inc.

      SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

      8/8/24 2:18:03 PM ET
      $SLP
      EDP Services
      Technology
    • SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

      SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

      2/13/24 5:13:58 PM ET
      $SLP
      EDP Services
      Technology
    • SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

      SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

      2/12/24 4:59:04 PM ET
      $SLP
      EDP Services
      Technology